• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Discov Med . Laboratory Biomarkers for the Diagnosis and Management of Patients with COVID-19: an Updated Review

tetano

Editor, Senior Moderator
Discov Med


. Mar-Apr 2021;31(163):61-68.

Laboratory Biomarkers for the Diagnosis and Management of Patients with COVID-19: an Updated Review


Bin-Bin Li[SUP] 1 [/SUP], Sheng-Jie Huang[SUP] 1 [/SUP], Yi-Long Fu[SUP] 1 [/SUP], Zhong-Lin Li[SUP] 1 [/SUP], Juan Wang[SUP] 1 [/SUP], Jin-Long Wang[SUP] 1 2 [/SUP]



Affiliations
  • PMID: 34965373

Abstract

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has become a global crisis due to strong infectivity and fast transmission speed. Some patients with Coronavirus Disease 2019 (COVID-19) progress rapidly and may develop fatal complications, which brings serious challenges in disease assessment and treatment. Recent progress in the understanding of the molecular biology of SARS-CoV-2 has led to the identification of a variety of laboratory biomarkers that could be potentially applied to clinical practice for the diagnosis, treatment, and prognosis of patients with COVID-19. In this review we summarize the updated status on the identification of COVID-19 related laboratory markers, and propose further direction on the application of these markers to clinical diagnosis and management of patients with COVID-19.
 
Back
Top Bottom